📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Strategic Trastuzumab Mediated Crosslinking Driving Concomitant HER2 and HER3 Endocytosis and Degradation in Breast Cancer. (2020)

First Author: Wymant JM

Attributed to: Laser-Guided nanoparticles and Cell Scalextrics funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.7150/jca.32470

PubMed Identifier: 32231734

Publication URI: http://europepmc.org/abstract/MED/32231734

Type: Journal Article/Review

Volume: 11

Parent Publication: Journal of Cancer

Issue: 11

ISSN: 1837-9664